Utilizing a filamentous fungus in the gut microbiome may provide a new strategy for treating metabolic dysfunction-associated ...

The researchers then investigated how the metabolisms of treated mice changed. They found that the effect was caused by ...

From a meeting that celebrates basic research and being "first," a look at 3 data sets on therapies that would break new ...

Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company developing precision genetic medicines for neuromuscular and ...

A drug candidate, previously successful at treating severe fatty liver disease, reduces atherosclerosis - a primary driver of cardiovascular death worldwide - in large mammals, a study suggests.

Non-alcoholic fatty liver disease (NAFLD) is a hepatic metabolic syndrome resulting from lipid metabolic imbalance.

Non-alcoholic fatty liver disease (NAFLD) is a hepatic metabolic syndrome resulting from lipid metabolic imbalance.

An “inverse vaccine” that delivers deactivated allergens to the liver was able to reduce reactions in mice with allergic asthma for at least a year after treatment. Should the approach ...

Liver-directed AAV-based gene therapy offers promise for people living with hemophilia B or other genetic disorders. 6,7,11–18 However, the long-term safety and efficacy of this approach remain ...

In the study, published in Circulation Research, the CNIC team developed a gene therapy using adeno-associated viruses (AAV)—a safe delivery ... of the experimental mice. The results are ...

The global humanized liver mice model market is on a strong growth trajectory, fueled by the increasing prevalence of liver diseases and significant technological advancements in genetic engineering.